Bifogade filer
Press release from the Extraordinary General Meeting in Vimian Group AB (publ) on 3 October 2022
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Vimian held its Extraordinary General Meeting today 3 October 2022. The Extraordinary General Meeting was conducted by postal voting only, without physical presence of shareholders, proxies and third parties, pursuant to temporary legislation.
The Extraordinary General Meeting unanimously resolved, in accordance with the board of directors’ proposal, to carry out a directed issue of not more than 32,500,000 new ordinary shares, entailing an increase in the share capital of not more than SEK 54,198.83223. The new share issue constitutes the second tranche in the issue of new shares announced by Vimian on 14 September 2022, in which Fidelio Vet Holding AB (“Fidelio”) committed to subscribe for 32,500,000 ordinary shares and Fidelio shall have the right to subscribe for the new ordinary shares. The reason for the new share issue and the deviation from the shareholders’ pre-emption rights is to carry out a capital raise in a time- and cost-effective manner to finance the company's acquisition agenda and reduce its indebtedness.
The subscription price is SEK 29 per ordinary share, which was determined in the accelerated book building procedure carried out by Carnegie Investment Bank AB (publ) on 14 September 2022.
More information about the resolution is available in the notice which is available on the company’s website, www.vimian.com.